{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:49:41Z","timestamp":1794710981399,"version":"4.9.1"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000096","name":"Scottish Rite Charitable Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["DGECR-2018\\u201300315"],"award-info":[{"award-number":["DGECR-2018\\u201300315"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2025.118949","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:25:13Z","timestamp":1767687913000},"page":"118949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cannflavin B ameliorates behavioural and neuronal systems alterations in adolescent rats exposed to prenatal valproic acid"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9326-5264","authenticated-orcid":false,"given":"Olivia O.F.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Coppolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-5286","authenticated-orcid":false,"given":"Joshua D.","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4906-1197","authenticated-orcid":false,"given":"Taylor C.","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1551-5485","authenticated-orcid":false,"given":"Paula T.","family":"Henry-Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talen C.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Soubeyrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-681X","authenticated-orcid":false,"given":"Tariq A.","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-8950","authenticated-orcid":false,"given":"Melissa L.","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118949_bib1","unstructured":"American psychiatric association, Diagnostic and statistical manual of mental disorders, Fifth Edition, 2013. \u3008https:\/\/dsm.psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425596\u3009 (accessed May 30, 2024)."},{"key":"10.1016\/j.biopha.2025.118949_bib2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.rasd.2013.07.003","article-title":"Comorbidity and autism: trends, topics and future directions","volume":"7","author":"Matson","year":"2013","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.biopha.2025.118949_bib3","article-title":"Cannabis and cannabinoid use in autism spectrum disorder: a systematic review","author":"da Silva","year":"2021","journal-title":"Trends Psychiatry Psychother. 44"},{"key":"10.1016\/j.biopha.2025.118949_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/jcph.70068","article-title":"Therapeutic use of cannabis derivatives and their analogs for autism spectrum disorder: a systematic review","author":"Riera","year":"2025","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib5","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s10803-018-3808-2","article-title":"Brief report: cannabidiol-rich cannabis in children with autism spectrum disorder and severe behavioral problems-a retrospective feasibility study","volume":"49","author":"Aran","year":"2019","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.biopha.2025.118949_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1210155","article-title":"Individually tailored dosage regimen of full-spectrum cannabis extracts for autistic core and comorbid symptoms: a real-life report of multi-symptomatic benefits","volume":"14","author":"Montagner","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.01145","article-title":"Effects of CBD-enriched Cannabis sativa extract on autism spectrum disorder symptoms: an observational study of 18 participants undergoing compassionate use","volume":"10","author":"Fleury-Teixeira","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2025.118949_bib8","doi-asserted-by":"crossref","DOI":"10.1089\/can.2024.0001","article-title":"Effects of medical cannabis treatment for autistic children on anxiety and restricted and repetitive behaviors and interests: an open-label study","author":"David","year":"2024","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.biopha.2025.118949_bib9","article-title":"Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial","author":"da Silva Junior","year":"2024","journal-title":"Trends Psychiatry Psychother. 46"},{"key":"10.1016\/j.biopha.2025.118949_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41398-022-02104-8","article-title":"Children and adolescents with ASD treated with CBD-rich cannabis exhibit significant improvements particularly in social symptoms: an open label study","volume":"12","author":"Hacohen","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3389\/fphar.2018.01521","article-title":"Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities","volume":"9","author":"Barchel","year":"2019","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s10803-025-06884-y","article-title":"Cannabidiol (CBD) treatment for severe problem behaviors in autistic boys: a randomized clinical trial","author":"Trauner","year":"2025","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.biopha.2025.118949_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41598-018-37570-y","article-title":"Real life experience of medical cannabis treatment in autism: analysis of safety and efficacy","volume":"9","author":"Bar-Lev Schleider","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118949_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ph17060686","article-title":"Clinical and family implications of cannabidiol (CBD)-dominant full-spectrum phytocannabinoid extract in children and adolescents with moderate to severe non-syndromic autism spectrum disorder (ASD): an observational study on neurobehavioral management","volume":"17","author":"de","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2025.118949_bib15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/0006-2952(85)90325-9","article-title":"Isolation from Cannabis sativa L. of cannflavin\u2014a novel inhibitor of prostaglandin production","volume":"34","author":"Barrett","year":"1985","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.phanu.2014.05.001","article-title":"Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"2","author":"Werz","year":"2014","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.biopha.2025.118949_bib17","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.3390\/jcm12103520","article-title":"The emerging role of flavonoids in autism spectrum disorder: a systematic review","volume":"12","author":"Savino","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.118949_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.08.011","article-title":"Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid \u03b2-mediated neurotoxicity in PC12 cells: comparison with geranylated flavonoids, mimulone and diplacone","volume":"169","author":"Eggers","year":"2019","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib19","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.3390\/nu15214565","article-title":"Cannflavins A and B with anti-ferroptosis, anti-glycation, and antioxidant activities protect human keratinocytes in a cell death model with erastin and reactive carbonyl species","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118949_bib20","article-title":"Interference of neuronal TrkB signaling by the cannabis-derived flavonoids cannflavins A and B","volume":"3","author":"Holborn","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2025.118949_bib21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s12035-016-9721-9","article-title":"Elevated serum brain-derived neurotrophic factor (BDNF) but not BDNF gene Val66Met polymorphism is associated with autism spectrum disorders","volume":"54","author":"Meng","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74239-x","article-title":"Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder","volume":"10","author":"Barbosa","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118949_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2005.07.004","article-title":"Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, landau-kleffner syndrome, and epilepsy","volume":"59","author":"Connolly","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib24","first-page":"15","article-title":"Dynamic Akt\/mTOR signaling in children with autism spectrum disorder","volume":"5","author":"Onore","year":"2017","journal-title":"Front Pedia"},{"key":"10.1016\/j.biopha.2025.118949_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/s41380-024-02806-z","article-title":"Monoallelic loss-of-function variants in GSK3B lead to autism and developmental delay","volume":"30","author":"Tan","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9603751","article-title":"Synaptic Wnt\/GSK3\u03b2 signaling hub in autism","volume":"2016","author":"Caracci","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2025.118949_bib27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1080\/20473869.2023.2185959","article-title":"NRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study","volume":"70","author":"Subasi Turgut","year":"2024","journal-title":"Int J. Dev. Disabil."},{"key":"10.1016\/j.biopha.2025.118949_bib28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s10571-020-01020-z","article-title":"GSK-3\u03b2 disrupts neuronal oscillatory function to inhibit learning and memory in male rats","volume":"42","author":"Albeely","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fnagi.2017.00434","article-title":"Disparate effects of lithium and a GSK-3 inhibitor on neuronal oscillatory activity in prefrontal cortex and hippocampus","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/978-1-4939-9554-7_29","article-title":"The contribution of inflammation to autism spectrum disorders: recent clinical evidence","volume":"2011","author":"Prata","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118949_bib31","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.3390\/ijms24065487","article-title":"Neuroinflammation and oxidative stress in the pathogenesis of autism spectrum disorder","volume":"24","author":"Usui","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pca.787","article-title":"NMR assignments of the major cannabinoids and cannabi\ufb02avonoids isolated from flowers of Cannabis sativa","volume":"15","author":"Choi","year":"2004","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.biopha.2025.118949_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2025.118949_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.biopha.2025.118949_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.biopha.2025.118949_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/cns.12648","article-title":"Beneficial effects of co-ultramicronized palmitoylethanolamide\/luteolin in a mouse model of autism and in a case report of autism","volume":"23","author":"Bertolino","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2025.118949_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jdn.10025","article-title":"Quercetin prevents alterations of behavioral parameters, delta-aminolevulinic dehydratase activity, and oxidative damage in brain of rats in a prenatal model of autism","volume":"80","author":"da","year":"2020","journal-title":"Int J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112960","article-title":"Postnatal baicalin ameliorates behavioral and neurochemical alterations in valproic acid-induced rodent model of autism: the possible implication of sirtuin-1\/mitofusin-2\/ Bcl-2 pathway","volume":"150","author":"Elesawy","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2023.104090","article-title":"Prenatally VPA exposure is likely to cause autistic-like behavior in the rats offspring via TREM2 down-regulation to affect the microglial activation and synapse alterations","volume":"99","author":"Luo","year":"2023","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib41","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.3390\/ijms21103576","article-title":"Prenatal exposure to valproic acid affects microglia and synaptic ultrastructure in a brain-region-specific manner in young-adult male rats: relevance to autism spectrum disorders","volume":"21","author":"G\u0105ssowska-Dobrowolska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104441","article-title":"Sex-specific effects of prenatal valproic acid exposure on sociability and neuroinflammation: relevance for susceptibility and resilience in autism","volume":"110","author":"Kazlauskas","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.biopha.2025.118949_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mcn.2014.01.007","article-title":"Increased BDNF expression in fetal brain in the valproic acid model of autism","volume":"59","author":"Almeida","year":"2014","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib44","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jfma.2018.06.017","article-title":"Valproate is protective against 6-OHDA-induced dopaminergic neurodegeneration in rodent midbrain: a potential role of BDNF up-regulation","volume":"118","author":"Lai","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.biopha.2025.118949_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mcn.2016.06.004","article-title":"Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats","volume":"75","author":"Qin","year":"2016","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib46","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1007\/s12035-016-0074-1","article-title":"Alleviation of n-methyl-d-aspartate receptor-dependent long-term depression via regulation of the glycogen synthase kinase-3\u03b2 pathway in the amygdala of a valproic acid-induced animal model of autism","volume":"54","author":"Wu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111222","article-title":"Prenatal exposure to valproic acid induces sex-specific alterations in rat cortical and hippocampal neuronal structure and function in vitro","volume":"136","author":"Williams","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3389\/fncel.2019.00367","article-title":"Cannabidivarin treatment ameliorates autism-like behaviors and restores hippocampal endocannabinoid system and glia alterations induced by prenatal valproic acid exposure in rats","volume":"13","author":"Zamberletti","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib49","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/mnfr.201300134","article-title":"Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3K\/Akt signaling pathway","volume":"57","author":"Schwanke","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2025.118949_bib50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41467-017-02794-5","article-title":"Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118949_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/mps8050100","article-title":"Development and validation of an HPLC\u2013UV\/PDA method for the determination of cannflavins in different Cannabis sativa chemovars","volume":"8","author":"Elhendawy","year":"2025","journal-title":"Methods Protoc."},{"key":"10.1016\/j.biopha.2025.118949_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.phytochem.2019.05.009","article-title":"Biosynthesis of cannflavins A and B from Cannabis sativa L","volume":"164","author":"Rea","year":"2019","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2025.118949_bib53","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/foods9030374","article-title":"The Pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin","volume":"9","author":"Batiha","year":"2020","journal-title":"Foods"},{"key":"10.1016\/j.biopha.2025.118949_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-8994-2_4","article-title":"The elevated plus maze test for measuring anxiety-like behavior in rodents","volume":"1916","author":"Kraeuter","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118949_bib55","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118949_bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.schres.2024.04.002","article-title":"Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia","volume":"267","author":"Albeely","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.biopha.2025.118949_bib57","unstructured":"G. Paxinos, C. Watson, 2005, The rat brain in sterotaxic coordinates, 2005."},{"key":"10.1016\/j.biopha.2025.118949_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainresbull.2023.04.004","article-title":"Prefrontal functional connectivities in autism spectrum disorders: a connectopathic disorder affecting movement, interoception, and cognition","volume":"198","author":"Leisman","year":"2023","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.biopha.2025.118949_bib59","article-title":"Functional connectivity of the caudal anterior cingulate cortex is decreased in autism","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118949_bib60","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2021.08.005","article-title":"Hippocampal contributions to social and cognitive deficits in autism spectrum disorder","volume":"44","author":"Banker","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2774","article-title":"Negative symptoms abnormal neural oscillations and synchrony in schizophrenia","volume":"11","author":"Uhlhaas","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2013.00609","article-title":"Altered neural connectivity in excitatory and inhibitory cortical circuits in autism","volume":"7","author":"Zikopoulos","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13229-024-00598-1","article-title":"The relationship between gamma-band neural oscillations and language skills in youth with autism spectrum disorder and their first-degree relatives","volume":"15","author":"Arutiunian","year":"2024","journal-title":"Mol. Autism"},{"key":"10.1016\/j.biopha.2025.118949_bib64","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating \u03b3 oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib65","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1089\/can.2023.0128","article-title":"Chemistry and biological activities of cannflavins of the cannabis plant","volume":"8","author":"Abdel-Kader","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.biopha.2025.118949_bib66","article-title":"Prostaglandin E2 and receptors: insight into tumorigenesis, tumor progression, and treatment of hepatocellular carcinoma","volume":"10","author":"Chen","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118949_bib67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trecan.2016.12.002","article-title":"Prostaglandin E2 signaling: alternative target for glioblastoma?","volume":"3","author":"Jiang","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.biopha.2025.118949_bib68","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10426","article-title":"Different chemical structures and physiological\/pathological roles of cyclooxygenases","volume":"12","author":"Faki","year":"2021","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.biopha.2025.118949_bib69","first-page":"83","article-title":"The remarkable mechanism of prostaglandin E2 on synaptic plasticity","volume":"1","author":"Akaneya","year":"2008","journal-title":"Gene Regul. Syst. Bio"},{"key":"10.1016\/j.biopha.2025.118949_bib70","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1523\/JNEUROSCI.2152-17.2018","article-title":"Prostaglandin signaling governs spike timing-dependent plasticity at sensory synapses onto mouse spinal projection neurons","volume":"38","author":"Li","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib71","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164153","article-title":"Identification of biomarkers of impaired sensory profiles among autistic patients","volume":"11","author":"El-Ansary","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118949_bib73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-511X-11-160","article-title":"Lipid mediators in plasma of autism spectrum disorders","volume":"11","author":"El-Ansary","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2025.118949_bib74","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s11011-018-0206-6","article-title":"Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder","volume":"33","author":"Qasem","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2025.118949_bib75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s40473-024-00294-7","article-title":"Roles of prostaglandins and cyclooxygenases in autism spectrum disorder: a comprehensive review","volume":"12","author":"Kamal","year":"2025","journal-title":"Curr. Behav. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2025.118949_bib76","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1471-4159.2005.03302.x","article-title":"Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production","volume":"94","author":"Ikeda-Matsuo","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2025.118949_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577724","article-title":"Prostaglandin E2 increases the expression of cyclooxygenase-2 in cultured rat microglia","volume":"361","author":"Nagano","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.biopha.2025.118949_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jare.2024.07.018","article-title":"CRISPR\/Cas9-mediated neuronal deletion of 5-lipoxygenase alleviates deficits in mouse models of epilepsy","volume":"63","author":"Guan","year":"2024","journal-title":"J. Adv. Res"},{"key":"10.1016\/j.biopha.2025.118949_bib79","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1007\/s12035-019-01742-2","article-title":"Oxidative stress in autism spectrum disorder","volume":"57","author":"Bj\u00f8rklund","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib80","article-title":"Oxidative stress in autism spectrum disorder\u2014current progress of mechanisms and biomarkers","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib81","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.3390\/ijms23169259","article-title":"Attenuation of autism-like behaviors by an anthocyanin-rich extract from Portuguese blueberries via microbiota\u2013gut\u2013brain axis modulation in a valproic acid mouse model","volume":"23","author":"Serra","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/dneu.22969","article-title":"Cannabis oil protects against valproic acid\u2013induced autism spectrum disorder by reducing oxidative stress","volume":"85","author":"Ali","year":"2025","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173919","article-title":"Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice","volume":"247","author":"Pedrazzi","year":"2025","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.biopha.2025.118949_bib84","article-title":"Effects of cannabidiol isolated or in association with risperidone in an animal model of autism","volume":"85","author":"de","year":"2025","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: no \u201cstrain,\u201d no gain","volume":"9","author":"Russo","year":"2019","journal-title":"Front Plant Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopha.2025.118949_bib87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicol Teratol."},{"key":"10.1016\/j.biopha.2025.118949_bib88","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1074\/jbc.M111.296020","article-title":"Modulation of l-\u03b1-lysophosphatidylinositol\/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids","volume":"287","author":"Anavi-Goffer","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118949_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111178","article-title":"Cannabidiol exerts antipyretic effects by downmodulating inflammatory mediators in LPS-induced fever","volume":"136","author":"Andres","year":"2025","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib91","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1601-183X.2010.00627.x","article-title":"Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF\/TrkB signaling in autism","volume":"9","author":"Correia","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.biopha.2025.118949_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbrc.2007.02.135","article-title":"Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism","volume":"356","author":"Nishimura","year":"2007","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2025.118949_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2017.07.008","article-title":"Inhibition of TrkB at the nucleus accumbens, using ANA-12, regulates basal and stress-induced orexin A expression within the mesolimbic system and affects anxiety, sociability and motivation","volume":"125","author":"Azogu","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2025.118949_bib94","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib95","first-page":"219","article-title":"Neurodevelopmental perspectives on Wnt signaling in psychiatry","volume":"2","author":"Mulligan","year":"2017","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/09540260701877670","article-title":"Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders","volume":"20","author":"Ances","year":"2008","journal-title":"Int Rev. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib97","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jnr.23192","article-title":"Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice","volume":"91","author":"King","year":"2013","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2025.118949_bib98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3233\/JAD-2006-9S335","article-title":"GSK-3 is essential in the pathogenesis of Alzheimer\u2019s disease","volume":"9","author":"Takashima","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.biopha.2025.118949_bib99","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.neuropharm.2012.07.028","article-title":"Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3\u03b2\/\u03b2-catenin pathway","volume":"63","author":"Go","year":"2012","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.biopha.2025.118949_bib100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-7610.2006.01531.x","article-title":"Development in infants with autism spectrum disorders: a prospective study","volume":"47","author":"Landa","year":"2006","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib101","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10803-004-2544-y","article-title":"Early indicators of autism spectrum disorders in the second year of life","volume":"34","author":"Wetherby","year":"2004","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.biopha.2025.118949_bib102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-52498-6_2","article-title":"Neuroanatomy and neuropathology of autism spectrum disorder in humans","volume":"224","author":"Ecker","year":"2017","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118949_bib103","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neubiorev.2016.10.002","article-title":"Brain oscillations and connectivity in autism spectrum disorders (ASD): new approaches to methodology, measurement and modelling","volume":"71","author":"Kessler","year":"2016","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.biopha.2025.118949_bib104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.yebeh.2012.01.015","article-title":"Epilepsy and autism: is there a special relationship?","volume":"23","author":"Berg","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.biopha.2025.118949_bib105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1203\/PDR.0b013e31819e7168","article-title":"The role of epilepsy and epileptiform EEGs in autism spectrum disorders","volume":"65","author":"Spence","year":"2009","journal-title":"Pedia Res"},{"key":"10.1016\/j.biopha.2025.118949_bib106","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/088307380201700908","article-title":"Clinical and macroscopic correlates of minicolumnar pathology in autism","volume":"17","author":"Casanova","year":"2002","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.biopha.2025.118949_bib107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.conb.2005.03.001","article-title":"Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection","volume":"15","author":"Courchesne","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1467-7687.2007.00634.x","article-title":"Growth-related neural reorganization and the autism phenotype: a test of the hypothesis that altered brain growth leads to altered connectivity","volume":"11","author":"Lewis","year":"2008","journal-title":"Dev. Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib109","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamapsychiatry.2015.0101","article-title":"Increased functional connectivity between subcortical and cortical resting-state networks in autism spectrum disorder","volume":"72","author":"Cerliani","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib110","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hbm.23084","article-title":"Reorganization of functionally connected brain subnetworks in high-functioning autism","volume":"37","author":"Glerean","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.biopha.2025.118949_bib111","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/aur.1589","article-title":"Subregional differences in intrinsic amygdala hyperconnectivity and hypoconnectivity in autism spectrum disorder","volume":"9","author":"Kleinhans","year":"2016","journal-title":"Autism Res"},{"key":"10.1016\/j.biopha.2025.118949_bib112","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/brainsci15040388","article-title":"Sex-specific behavioral features of the prenatal valproic acid rat model of autism spectrum disorder","volume":"15","author":"Mamali","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2025.118949_bib113","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118949_bib114","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1007\/s12035-024-04491-z","article-title":"Animal model of autism induced by valproic acid combined with maternal deprivation: sex-specific effects on inflammation and oxidative stress","volume":"62","author":"Campos","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2025.118949_bib115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpsycho.2004.03.001","article-title":"Alpha oscillations as a correlate of trait anxiety","volume":"53","author":"Knyazev","year":"2004","journal-title":"Int J. Psychophysiol."},{"key":"10.1016\/j.biopha.2025.118949_bib116","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biopsycho.2009.11.010","article-title":"Frontal brain oscillations and social anxiety: a cross-frequency spectral analysis during baseline and speech anticipation","volume":"83","author":"Miskovic","year":"2010","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.biopha.2025.118949_bib117","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jphysparis.2014.04.003","article-title":"Frontal midline theta reflects anxiety and cognitive control: meta-analytic evidence","volume":"109","author":"Cavanagh","year":"2015","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.biopha.2025.118949_bib118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopsych.2021.08.020","article-title":"Midfrontal theta activity in psychiatric illness: an index of cognitive vulnerabilities across disorders","volume":"91","author":"McLoughlin","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2025.118949_bib119","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.3390\/s22145420","article-title":"Aberrated multidimensional EEG characteristics in patients with generalized anxiety disorder: a machine-learning based analysis framework","volume":"22","author":"Shen","year":"2022","journal-title":"Sensors"},{"key":"10.1016\/j.biopha.2025.118949_bib120","series-title":"Proc of the 2023 10th Int Conf on Biomed and Bioinf Eng","first-page":"201","article-title":"Abnormal oscillations in beta and gamma of generalized anxiety disorder patients based on resting state EEG","author":"Liang","year":"2024"},{"key":"10.1016\/j.biopha.2025.118949_bib121","doi-asserted-by":"crossref","first-page":"443","DOI":"10.30773\/pi.2022.0011","article-title":"State and trait anxiety related gamma oscillations in patients with anxiety within the research domain criteria framework","volume":"19","author":"Kim","year":"2022","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.biopha.2025.118949_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.630813","article-title":"Increase in beta power reflects attentional top-down modulation after psychosocial stress induction","volume":"15","author":"Palacios-Garc\u00eda","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.biopha.2025.118949_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2022.101010","article-title":"Sex hormone fluctuation and increased female risk for depression and anxiety disorders: from clinical evidence to molecular mechanisms","volume":"66","author":"Kundakovic","year":"2022","journal-title":"Front. Neuroendocr."},{"key":"10.1016\/j.biopha.2025.118949_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/srep46381","article-title":"Development and validation of a method for precise dating of female puberty in laboratory rodents: the puberty ovarian maturation score (Pub-Score)","volume":"7","author":"Gaytan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118949_bib125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:10:38Z","timestamp":1773947438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":125,"alternative-id":["S0753332225011436"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118949","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannflavin B ameliorates behavioural and neuronal systems alterations in adolescent rats exposed to prenatal valproic acid","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118949"}}